These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22840347)

  • 1. Meta-analysis of safety of the coadministration of statin with fenofibrate in patients with combined hyperlipidemia.
    Guo J; Meng F; Ma N; Li C; Ding Z; Wang H; Hou R; Qin Y
    Am J Cardiol; 2012 Nov; 110(9):1296-301. PubMed ID: 22840347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):219-26. PubMed ID: 23324122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Choi IS; Shin EK
    J Am Coll Cardiol; 2005 May; 45(10):1649-53. PubMed ID: 15893182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.
    Ellen RL; McPherson R
    Am J Cardiol; 1998 Feb; 81(4A):60B-65B. PubMed ID: 9526816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients.
    Unal A; Torun E; Sipahioglu MH; Tokgoz B; Kaya MG; Oymak O; Utas C
    Intern Med; 2008; 47(11):1017-9. PubMed ID: 18520113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
    Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
    Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials.
    Farnier M; Marcereuil D; De Niet S; Ducobu J; Steinmetz A; Retterstøl K; Bryniarski L; Császár A; Vanderbist F
    Clin Drug Investig; 2012 Apr; 32(4):281-91. PubMed ID: 22350498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fenofibrate as an add-on in patients with elevated triglyceride despite receiving statin treatment.
    Zhao S; Wang F; Dai Y; Lin L; Tong Q; Liao Y; Yin Y; Wang G; Yan Y; Li X; Wang D; Wei P; Cheng X; Xie Q; Sun Y; Fu G; Huang H; Dong Y; Liu J; Yan J; Yan L; Cui S; Liu X; Li Z; Chen H; Hu T; Gong H
    Int J Cardiol; 2016 Oct; 221():832-6. PubMed ID: 27434354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
    Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
    Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety considerations with fenofibrate/simvastatin combination.
    Filippatos TD; Elisaf MS
    Expert Opin Drug Saf; 2015; 14(9):1481-93. PubMed ID: 26134595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles.
    Wang TD; Chen WJ; Lin JW; Cheng CC; Chen MF; Lee YT
    Atherosclerosis; 2003 Oct; 170(2):315-23. PubMed ID: 14612213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of alternate-day simvastatin and fenofibrate on mixed hyperlipidemia.
    Kayikçioğlu M; Ozerkan F; Soydan I
    Am J Cardiol; 1999 Apr; 83(7):1135-7, A9. PubMed ID: 10190536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
    Kei A; Tellis C; Liberopoulos E; Tselepis A; Elisaf M
    Cardiovasc Ther; 2014 Aug; 32(4):139-46. PubMed ID: 24618208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.
    Koh KK; Quon MJ; Rosenson RS; Chung WJ; Han SH
    Int J Cardiol; 2008 Feb; 124(2):149-59. PubMed ID: 17658632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study.
    Park MS; Youn JC; Kim EJ; Han KH; Lee SH; Kim SH; Kim BJ; Kwon SU; Ryu KH
    Clin Ther; 2021 Oct; 43(10):1735-1747. PubMed ID: 34518033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study.
    Kwon TG; Jang AY; Kim SW; Hong YJ; Bae JH; Lee SY; Kim SH; Han SH
    Trials; 2020 Apr; 21(1):353. PubMed ID: 32321551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A meta-analysis on the safety of combination therapy with fenofibrate and statins].
    Geng Q; Ren JY; Li SF; Chen H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1063-8. PubMed ID: 24524615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
    Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I
    Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.